HUP9903679A3 - Use of olanzapine for the preparation of pharmaceutical compositions treating bipolar disorder - Google Patents

Use of olanzapine for the preparation of pharmaceutical compositions treating bipolar disorder

Info

Publication number
HUP9903679A3
HUP9903679A3 HU9903679A HUP9903679A HUP9903679A3 HU P9903679 A3 HUP9903679 A3 HU P9903679A3 HU 9903679 A HU9903679 A HU 9903679A HU P9903679 A HUP9903679 A HU P9903679A HU P9903679 A3 HUP9903679 A3 HU P9903679A3
Authority
HU
Hungary
Prior art keywords
olanzapine
preparation
pharmaceutical compositions
bipolar disorder
treating bipolar
Prior art date
Application number
HU9903679A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of HUP9903679A2 publication Critical patent/HUP9903679A2/hu
Publication of HUP9903679A3 publication Critical patent/HUP9903679A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
HU9903679A 1996-03-11 1996-12-04 Use of olanzapine for the preparation of pharmaceutical compositions treating bipolar disorder HUP9903679A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1315996P 1996-03-11 1996-03-11

Publications (2)

Publication Number Publication Date
HUP9903679A2 HUP9903679A2 (hu) 2000-04-28
HUP9903679A3 true HUP9903679A3 (en) 2001-10-29

Family

ID=21758606

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9903679A HUP9903679A3 (en) 1996-03-11 1996-12-04 Use of olanzapine for the preparation of pharmaceutical compositions treating bipolar disorder

Country Status (15)

Country Link
EP (1) EP0889725A4 (cs)
JP (1) JP2000506859A (cs)
KR (1) KR19990087713A (cs)
CN (1) CN1213966A (cs)
AU (1) AU734011B2 (cs)
BR (1) BR9612548A (cs)
CZ (1) CZ290298A3 (cs)
EA (1) EA000758B1 (cs)
HU (1) HUP9903679A3 (cs)
IL (1) IL126162A0 (cs)
NO (1) NO984189D0 (cs)
NZ (1) NZ326031A (cs)
PL (1) PL328925A1 (cs)
TR (1) TR199801797T2 (cs)
WO (1) WO1997033577A1 (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0101901A3 (en) * 1998-05-22 2002-06-28 Lilly Co Eli Pharmaceutical composition for combined therapeutic treatment of refractory depression and combined treating process
US6960577B2 (en) 1998-05-22 2005-11-01 Eli Lilly And Company Combination therapy for treatment of refractory depression
BR9911068A (pt) * 1998-05-29 2001-02-06 Lilly Co Eli Terapia combinada para tratamento de distúrbios bipolares
EP1133299A1 (en) 1998-11-23 2001-09-19 Sepracor Inc. 2-hydroxymethylolanzapine compositions and methods
CA2351718A1 (en) 1998-11-23 2000-06-02 Sepracor Inc. Desmethylolanzapine compositions and methods
JP2002530340A (ja) * 1998-11-23 2002-09-17 セプラコール， インク． オランザピン−ｎ−オキサイドを含む医薬組成物
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
US5457101A (en) * 1994-06-03 1995-10-10 Eli Lilly And Company Thieno[1,5]benzoidiazepine use

Also Published As

Publication number Publication date
CZ290298A3 (cs) 1999-10-13
PL328925A1 (en) 1999-03-01
TR199801797T2 (xx) 1998-12-21
EA000758B1 (ru) 2000-04-24
HUP9903679A2 (hu) 2000-04-28
NO984189L (no) 1998-09-11
EA199800819A1 (ru) 1999-02-25
JP2000506859A (ja) 2000-06-06
AU734011B2 (en) 2001-05-31
AU1330797A (en) 1997-10-01
NO984189D0 (no) 1998-09-11
EP0889725A1 (en) 1999-01-13
IL126162A0 (en) 1999-05-09
WO1997033577A1 (en) 1997-09-18
NZ326031A (en) 2001-05-25
EP0889725A4 (en) 2000-01-19
KR19990087713A (ko) 1999-12-27
BR9612548A (pt) 1999-07-20
CN1213966A (zh) 1999-04-14

Similar Documents

Publication Publication Date Title
IL125735A0 (en) Pharmaceutical compositions for the treatment of glaucoma
HUP0001607A3 (en) Thienopyrimidine derivatives, pharmaceutical compositions containing them, process for their preparation and use of the compounds
IL119833A0 (en) Plant extracts for the preparation of pharmaceutical compositions for the treatment of hepatitis
HUP0102556A3 (en) Benzenesulfonamide-derivatives and their use as medicaments and process for the preparation of the compounds
HUP9903489A3 (en) Use of epinastine for the preparation of pharmaceutical compositions treating pain
HUP9700328A3 (en) Heteroaryl-oxazolidinones, process for their preparation, pharmaceutical compositions containing the same, their use and intermediates
EP0943327A4 (en) DRUG
HUP9900974A3 (en) Heterocycle-condensed morphinoid derivatives, process for the preparation thereof, their use and pharmaceutical compositions containing them
IL138129A (en) Composition for therapy of estrogen-associated disorders
AP2000002010A0 (en) Novel pharmaceutical compositions for treating and saving and the methods for the preparation thereof
HUP0003851A3 (en) Pharmaceutical composition for the treatment or prevention of glomerulopathy
HUP9903166A3 (en) Medicinal compositions for the prophylaxis or treatment of arteriosclerosis
GB2311940B (en) Pharmaceutical compositions for the treatment of rhinitis
HUP9900886A3 (en) Use of bisphosphonates preventing bone loss associated with immunosuppressive therapy for the preparation of pharmaceutical compositions
HUP9901326A3 (en) Benzopyran derivatives having leukotriene-antagonistic action, pharmaceutical compositions containing these compounds, process for the preparation and use of these compounds and compositions
HUP9901434A3 (en) Substituted benzylamines and their use for the preparation of medicaments for treating depression
AU4133997A (en) Pharmaceutical composition for the treatment of syndrome x of reaven
HUP9903684A3 (en) Use of olanzapine for the preparation of pharmaceutical compositions treating depression
HUP0003679A3 (en) Use of pkc inhibitors for the preparation of pharmaceutical compositions treating cardiovascular diseases
IL119225A (en) Pharmaceutical compositions for the treatment of asthma in mammals
HUP9903679A3 (en) Use of olanzapine for the preparation of pharmaceutical compositions treating bipolar disorder
IL121096A0 (en) Pharmaceutical compositions for the treatment of liver disease
HUP9903688A3 (en) Use of olanzapine for the preparation of pharmaceutical compositions treating autism
HUP9904173A3 (en) Pharmaceutical composition for treating viral diseases
HUP0003159A3 (en) The use of n-monosubstituted-3-oxo-4-aza-5alpha-androst-1-en-17betha-carboxamides for the preparation of pharmaceutical compositions